Relationship between estrogen receptor (ER) status and efficacy of postoperative adjuvant chemotherapy with oral tegafur-uracil (UFT) or CMF: subset analysis from a randomized controlled trial (CUBC trial in Japan)

被引：2

|

作者：

Takatsuka, Y. ^{[1
]}

Park, Y. ^{[2
]}

Okamura, K. ^{[3
]}

Mitsuyama, S. ^{[4
]}

Saito, T. ^{[5
]}

Koh, J. ^{[6
]}

Kyono, S. ^{[7
]}

Inaji, H. ^{[8
]}

Koyama, H. ^{[8
]}

Suzuki, T. ^{[8
]}

机构：

[1] Kansai Rosai Hosp, Dept Breast Surg, Hyogo 2748510, Japan

[2] Toho Univ, Sakura Hosp, Sch Med, Chiba, Japan

[3] Kumamoto Rosai Hosp, Dept Surg, Kumamoto, Japan

[4] Kita Kyushu Municipal Med Ctr, Dept Surg, Fukuoka, Japan

[5] Omiya Red Cross Hosp, Dept Surg, Saitama, Japan

[6] Saitama Social Insurance Hosp, Dept Surg, Saitama, Japan

[7] Chiba Hokuso Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan

[8] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan

来源：

EJC SUPPLEMENTS | 2008年 / 6卷 / 07期

关键词：

D O I：

10.1016/S1359-6349(08)70551-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：117 / 118

页数：2

相关论文

共 13 条

[11] Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur
Watanabe M.
Nishida O.
Kunii Y.
Kodaira S.
Takahashi T.
Tominaga T.
Hojyo K.
Kato T.
Niimoto M.
Kunitomo K.
Isomoto H.
Ohashi Y.
Yasutomi M.
International Journal of Clinical Oncology, 2004, 9 (2) : 98 - 106
[12] Efficacy, toxicity and quality of life in older patients with early-stage breast cancer treated with oral Tegafur-uracil or classical CMF (cyclophosphamide, methotrexate, and fluorouracil): an exploratory analysis of National Surgical Adjuvant Study for Breast Cancer (N-SAS BC) 01 Trial
Hara, F.
Watanabe, T.
Shimozuma, K.
Ohashi, Y.
CANCER RESEARCH, 2012, 72
[13] Primary analysis from NEOS trial: A randomized phase III study that assessed the long-term prognosis of estrogen receptor positive (ER plus ) primary breast cancer (PBC) pts who received neoadjuvant endocrine therapy (NET) with/without adjuvant chemotherapy (CT)
Iwata, Hiroji
Toyama, Tatsuya
Taira, Naruto
Masuda, Norikazu
Yamamoto, Yutaka
Fujisawa, Tomomi
Ohtani, Shoichiro
Kashiwaba, Masahiro
Sakai, Takehiko
Hasegawa, Yoshie
Nakamura, Rikiya
Akabane, Hiromitsu
Shibahara, Yukiko
Sasano, Hironobu
Yamaguchi, Takuhiro
CANCER RESEARCH, 2022, 82 (04)